Persistent parvovirus B19 infections in immunocompromised children

被引:38
作者
Flunker, G
Peters, A
Wiersbitzky, S
Modrow, S
Seidel, W
机构
[1] Ernst Moritz Arndt Univ Greifswald, Abt Virol, Inst Med Mikrobiol, D-17487 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Kindermed, Zentrum Kinder & Jugendmed, D-17487 Greifswald, Germany
[3] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-93053 Regensburg, Germany
关键词
parvovirus B19 persistence; patients with immune defect; PCR; nonstructural protein; immune response;
D O I
10.1007/s004300050063
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunocompromised patients have been shown to suffer from prolonged viral infections often without detectable immune response. Here chronic infections with low virus levels can be frequently observed. In these patients viral DNA can be detected over long periods by polymerase chain reaction (PCR). In this study parvovirus B19 presence was assessed by PCR, immunoblot and enzyme-linked immunosorbent assay in sera from children with mainly oncological and hematological diseases. In 45% of sera B19 DNA was observed. Of the children 25% had IgG antibodies to viral protein 1 and 2 (VP1/2) and 15% to nonstructural protein 1 (NS 1). In 6% of children IgM antibodies to VP1/2 were detected. These results indicate that the number of children with immune response to B19 proteins is distinctly lower than the number of children with B19 DNA. Transfusions of blood products might have been a possible route for B19 infection. Establishment and maintenance of a persistent parvovirus B19 infection with or without immune response are enhanced in the analyzed immunocompromised children in comparison with immunocompetent children. A persistence of B19 DNA was demonstrated up to 10 months in patients sera.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 37 条
[1]  
ANDERSON LJ, 1997, CLIN VIROLOGY, P613
[2]   MOLECULAR, CELLULAR AND CLINICAL ASPECTS OF PARVOVIRUS B19 INFECTION [J].
BROWN, KE ;
YOUNG, NS ;
LIU, JM .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1994, 16 (01) :1-31
[3]   HUMAN PARVOVIRUS B19 INFECTION ASSOCIATED WITH PROLONGED ERYTHROBLASTOPENIA IN A LEUKEMIC CHILD [J].
CARSTENSEN, H ;
ORNVOLD, K ;
COHEN, BJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (01) :56-56
[4]   HUMAN PARVOVIRUS-B19 INFECTIONS - ROUTINE DIAGNOSIS BY A NEW NESTED POLYMERASE CHAIN-REACTION ASSAY [J].
CASSINOTTI, P ;
WEITZ, M ;
SIEGL, G .
JOURNAL OF MEDICAL VIROLOGY, 1993, 40 (03) :228-234
[5]   PERSISTENT HUMAN PARVOVIRUS B19 INFECTION FOLLOWING AN ACUTE INFECTION WITH MENINGITIS IN AN IMMUNOCOMPETENT PATIENT [J].
CASSINOTTI, P ;
SCHULTZE, D ;
SCHLAGETER, P ;
CHEVILI, S ;
SIEGL, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (09) :701-704
[6]  
Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P81
[7]   POLYMERASE CHAIN-REACTION ASSAY OF PARVOVIRUS B19 DNA IN CLINICAL SPECIMENS [J].
CLEWLEY, JP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) :2647-2651
[8]   BLOOD-DONOR SCREENING FOR PARVOVIRUS-B19 [J].
COHEN, BJ ;
FIELD, AM ;
GUDNADOTTIR, S ;
BEARD, S ;
BARBARA, JAJ .
JOURNAL OF VIROLOGICAL METHODS, 1990, 30 (03) :233-238
[9]  
DAHME M, 1994, METHODS IN DNA AMPLIFICATION, P179
[10]   PARVOVIRUS B19 INFECTION IN-HOSPITAL WORKERS - COMMUNITY OR HOSPITAL ACQUISITION [J].
DOWELL, SF ;
TOROK, TJ ;
THORP, JA ;
HEDRICK, J ;
ERDMAN, DD ;
ZAKI, SR ;
HINKLE, CJ ;
BAYER, WL ;
ANDERSON, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04) :1076-1079